RPS6 and lung carcinoma: The anticancer effect of RPS6-KD was reproduced in a xenograft model: A549 lung cancer cells with RPS6-KD resulted in reduced tumorigenicity with an increase in the number of SA-β-gal(+) cells in xenograft tissues.